Dr. Sherman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
88 Central Park West
New York, NY 10023Phone+1 917-570-2906Fax+1 212-496-5109
Education & Training
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1969 - 1971
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1969
Certifications & Licensure
IL State Medical License 1970 - Present
NJ State Medical License 1987 - Present
NY State Medical License 1973 - 2026
FL State Medical License 2000 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III) Start of enrollment: 2009 Dec 01
Publications & Presentations
PubMed
- 73 citationsThe gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysisRobert L. Fine, David R. Fogelman, Stephen M. Schreibman, Manisha Desai, William H. Sherman
Cancer Chemotherapy and Pharmacology. 2007-04-18 - 38 citationsNeoadjuvant Imatinib Therapy for Dermatofibrosarcoma ProtuberansAnne Han, Elbert H. Chen, George W. Niedt, William H. Sherman, Désirée Ratner
Archives of Dermatology. 2009-07-01 - 250 citationsPlasma-cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral-nerve myelin.Norman Latov, William H. Sherman, Raffaello Nemni, Giuliana Galassi, Joanna S. Shyong
The New England Journal of Medicine. 1980-09-11
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
